Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EFSA brings in timelines for GMO data submissions

New timelines for submitting additional data related to EU evaluations of genetically modified organisms come into force on May 1st. The European Food Safety Authority (EFSA) issued the indicative timelines earlier this year (Agrow No 682, p 13). For the first time, applicants have a clear idea of how long they have to provide data requested during assessments, the EFSA says. The new system aims to make evaluations as efficient and timely as possible, and will strengthen the predictability of what applicants can expect from the Authority, it adds. Nevertheless, the EFSA notes that further refinement may be necessary. “While EFSA will adhere to the guidelines wherever possible, we understand that applications will need to be treated on a case-by-case basis,” says Dr Per Bergman, who leads the Authority’s work on regulated products. The new timelines are on the EFSA website at: http://www.efsa.europa.eu/en/efsajournal/pub/3553.htm.

Topics

What to read next

UsernamePublicRestriction

Register

AG001791

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel